Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron Brennan

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Oncologist|March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar CarcinomaGhassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Cancer Cell|July 4, 2009
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesisLauren T McGillicuddy, Jody A Fromm, Pablo E Hollstein, et al.
Future Oncology (London, England)|December 7, 2023
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Nature|May 23, 2007
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersRichard S Maser, Bhudipa Choudhury, Peter J Campbell, et al.
Acta Neuropathologica|September 12, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumorsSubhiksha Nandakumar, Miika Mehine, Yelena Kemel, et al.
Nature Genetics|April 8, 2014
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutationsPawel Buczkowicz, Christine Hoeman, Patricia Rakopoulos, et al.
BMC Medical Genomics|April 27, 2019
Sequencing and curation strategies for identifying candidate glioblastoma treatmentsMayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, et al.
BMC Medical Genomics|August 4, 2019
Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatmentsMayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Oncologist|March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar CarcinomaGhassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Cancer Cell|July 4, 2009
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesisLauren T McGillicuddy, Jody A Fromm, Pablo E Hollstein, et al.
Future Oncology (London, England)|December 7, 2023
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Nature|May 23, 2007
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersRichard S Maser, Bhudipa Choudhury, Peter J Campbell, et al.
Acta Neuropathologica|September 12, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumorsSubhiksha Nandakumar, Miika Mehine, Yelena Kemel, et al.
Nature Genetics|April 8, 2014
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutationsPawel Buczkowicz, Christine Hoeman, Patricia Rakopoulos, et al.
BMC Medical Genomics|April 27, 2019
Sequencing and curation strategies for identifying candidate glioblastoma treatmentsMayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, et al.
BMC Medical Genomics|August 4, 2019
Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatmentsMayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, et al.
Pageof 9